CEACAMS 1, 5, and 6 in disease and cancer: Interactions with pathogens
A new review was recently published in Genes & Cancer, titled, "CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens."
Feb 10, 2023
0
2
A new review was recently published in Genes & Cancer, titled, "CEACAMS 1, 5, and 6 in disease and cancer: interactions with pathogens."
Feb 10, 2023
0
2
The global epidemic innovations fund said Tuesday it was working with a vaccine manufacturer to create a patch using mRNA technology, which would be easier to use against COVID.
Jan 17, 2023
0
5
Annual vaccinations against seasonal flu have become a way to protect the elderly and vulnerable in society, but the development of new flu vaccines is both expensive and time-consuming. There is therefore a great need for ...
Jan 11, 2023
0
1
Using new microscopic methods in combination with machine learning-based image analysis, researchers from Freiburg have discovered new structures on the surface of living B cells that affect the distribution and possibly ...
Jan 11, 2023
0
45
Hitting two targets at the same time may be the key to stopping the spread of aggressive cancers, according to new research from the University of East Anglia and the Quadram Institute.
Dec 12, 2022
0
20
Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant. The drug ...
Dec 7, 2022
0
540
The notorious spike protein of SARS-CoV-2, the virus that causes COVID-19, caused lung cancer cells to die in laboratory studies conducted by researchers at RUSH University Medical Center, who recently published their findings ...
Dec 6, 2022
0
154
Cambridge scientists have identified an off-patent drug that can be repurposed to prevent COVID-19—and may be capable of protecting against future variants of the virus—in research involving a unique mix of "mini-organs," ...
Dec 5, 2022
0
237
Immune responses against Factor VIII, which is used to treat hemophilia A (bleeding disorder), are influenced by the microenvironment of antigen presenting cells. This is the result of a scientific study conducted in cooperation ...
Nov 22, 2022
0
14
Researchers led by Osaka University have now identified a mechanism by which a lack of insulin may be reported back to the pancreatic cells that produce insulin, identifying a potential new therapeutic target for diabetes.
Nov 7, 2022
0
4